Impact of haemoglobin vesicles on pretransfusion testing and mitigation strategies

Documenti analoghi

• Is drug interference still an issue for pretransfusion testing of patients on anti CD38 and other monoclonal antibody therapies?
  di: Nichole Bevel, et al.
  Pubblicazione: (2024)
• Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries
  di: Amber Meulenbeld, et al.
  Pubblicazione: (2025)
• Correction to ‘Potential benefits of an alternative haemoglobin deferral strategy evaluated in seven countries’
  Pubblicazione: (2026)
• Challenges in promoting stewardship of albumin: A comparative perspective from recent guidelines
  di: Tomohiko Sato, et al.
  Pubblicazione: (2025)
• Effects of blood donor characteristics and storage on red blood cell haemoglobin β S‐nitrosylation
  di: Cuiping Zhang, et al.
  Pubblicazione: (2024)